You are here

  • Home
  • Archive
  • Volume 86, Issue 11
  • LONG-TERM SAFETY OF ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: PREGNANCY AND INFECTION DATA FROM A COHORT OF PATIENTS ON OPEN LABEL STUDIES IN CAMBRIDGE

Citation Tools

Article menu
Download PDFPDF
ABN abstracts 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London
Thur 21, Parallel session 5: Therapeutics
111
LONG-TERM SAFETY OF ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: PREGNANCY AND INFECTION DATA FROM A COHORT OF PATIENTS ON OPEN LABEL STUDIES IN CAMBRIDGE

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
McCarthy C, Tuohy O, Azzopardi L, et al
LONG-TERM SAFETY OF ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: PREGNANCY AND INFECTION DATA FROM A COHORT OF PATIENTS ON OPEN LABEL STUDIES IN CAMBRIDGE
Journal of Neurology, Neurosurgery & Psychiatry 2015;86:e4.